Literature DB >> 2144608

Functional analysis of the murine T-cell receptor beta enhancer and characteristics of its DNA-binding proteins.

J Takeda1, A Cheng, F Mauxion, C A Nelson, R D Newberry, W C Sha, R Sen, D Y Loh.   

Abstract

The minimal T-cell receptor (TCR) beta-chain (TCR beta) enhancer has been identified by transfection into lymphoid cells. The minimal enhancer was active in T cells and in some B-lineage cells. When a larger fragment containing the minimal enhancer was used, its activity was apparent only in T cells. Studies with phytohemagglutinin and 4 beta-phorbol-12,13-dibutyrate revealed that the enhancer activity was increased by these agents. By a combination of DNase I footprinting, gel mobility shift assay, and methylation interference analysis, seven different motifs were identified within the minimal enhancer. Furthermore, competition experiments showed that some of these elements bound identical or similar factors that are known to bind to the TCR V beta promoter decamer or to the immunoglobulin enhancer kappa E2 or muEBP-E motif. These shared motifs may be important in the differential gene activity among the different lymphoid subsets.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144608      PMCID: PMC361162          DOI: 10.1128/mcb.10.10.5027-5035.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Transcription from a murine T-cell receptor V beta promoter depends on a conserved decamer motif similar to the cyclic AMP response element.

Authors:  S J Anderson; S Miyake; D Y Loh
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

2.  T cell receptor DJ but not VDJ rearrangement within a recombination substrate introduced into a pre-B cell line.

Authors:  P Ferrier; L R Covey; H Suh; A Winoto; L Hood; F W Alt
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

3.  Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription.

Authors:  M S Schlissel; D Baltimore
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

4.  Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers.

Authors:  T W Hai; F Liu; W J Coukos; M R Green
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

Review 5.  Somatic generation of antibody diversity.

Authors:  S Tonegawa
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

6.  B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo.

Authors:  A Ephrussi; G M Church; S Tonegawa; W Gilbert
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

7.  The V(D)J recombination activating gene, RAG-1.

Authors:  D G Schatz; M A Oettinger; D Baltimore
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

8.  Introduction of a mu immunoglobulin gene into the mouse germ line: specific expression in lymphoid cells and synthesis of functional antibody.

Authors:  R Grosschedl; D Weaver; D Baltimore; F Costantini
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain.

Authors:  T Maekawa; H Sakura; C Kanei-Ishii; T Sudo; T Yoshimura; J Fujisawa; M Yoshida; S Ishii
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more
  29 in total

1.  Functionally distinct isoforms of the CRE-BP DNA-binding protein mediate activity of a T-cell-specific enhancer.

Authors:  K Georgopoulos; B A Morgan; D D Moore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

2.  Identification of a T-cell-specific enhancer at the locus encoding T-cell antigen receptor gamma chain.

Authors:  D J Kappes; C P Browne; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

3.  Stage-specific functions of E-proteins at the β-selection and T-cell receptor checkpoints during thymocyte development.

Authors:  Mary Elizabeth Jones; Yuan Zhuang
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

4.  Definition of a T-cell receptor beta gene core enhancer of V(D)J recombination by transgenic mapping.

Authors:  R K Tripathi; N Mathieu; S Spicuglia; D Payet; C Verthuy; G Bouvier; D Depetris; M G Mattei; W M HempeL; P Ferrier
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

5.  Identification of an essential site for transcriptional activation within the human T-cell receptor delta enhancer.

Authors:  J M Redondo; J L Pfohl; M S Krangel
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

6.  Direct and indirect mechanisms of repression participate in suppression of T-cell-specific gene expression in T x L-cell hybrids.

Authors:  L Shurman; R Laskov; Y Bergman
Journal:  Gene Expr       Date:  1996

7.  A novel POU domain protein which binds to the T-cell receptor beta enhancer.

Authors:  H Messier; H Brickner; J Gaikwad; A Fotedar
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

8.  GATA elements are necessary for the activity and tissue specificity of the T-cell receptor beta-chain transcriptional enhancer.

Authors:  A J Henderson; S McDougall; J Leiden; K L Calame
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

9.  p70 lupus autoantigen binds the enhancer of the T-cell receptor beta-chain gene.

Authors:  H Messier; T Fuller; S Mangal; H Brickner; S Igarashi; J Gaikwad; R Fotedar; A Fotedar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  Human T cell transcription factor GATA-3 stimulates HIV-1 expression.

Authors:  Z Yang; J D Engel
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.